| Previous Close | 34.06 |
| Open | 34.08 |
| Bid | 34.10 x 3500 |
| Ask | 34.11 x 4100 |
| Day's Range | 34.00 - 34.22 |
| 52 Week Range | 29.83 - 37.39 |
| Volume | 2,560,754 |
| Avg. Volume | 21,575,643 |
| Market Cap | 203.83B |
| Beta | 1.06 |
| PE Ratio (TTM) | 28.75 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.78%) |
| Ex-Dividend Date | 2017-05-10 |
| 1y Target Est | N/A |
- TheStreet.com•13 minutes ago
Biotech Movers: Regeneron Slides Back After Big Gains
The main headwind for Regeneron is that Swiss pharma giant Novartis could soon be a rival to the eye drug that drives most of Regeneron's revenue.
- Market Realist•1 hour ago
Vertex on the Street: Analysts’ Recommendations in June 2017
Vertex (VRTX) has planned to submit a new drug application to the FDA in 3Q17 for a Tezacaftor-Ivacaftor combination treatment for cystic fibrosis.
- TheStreet.com•2 hours ago
15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
Here are the names.
